Skip to content.

Portale di neuroinformatica

Sections
  • Home
  • The project
  • The group
  • Contact
    		•  
  • Citizen
  • Doctor
  • Researcher
    • Personal tools
    You are here: Home » Researcher » Bibliografia » Bibliografia Malattia di Alzheimer
     

    Bibliografia Malattia di Alzheimer




    Diagnosi con la PET


    1. Okamura N.
      [In vivo imaging of amyloid plaques in the brain]
      Nippon Ronen Igakkai Zasshi. 2004 Mar;41(2):175-8. Japanese.
    2. Jeong Y, Chin J, Tae WS, Hong SB, Kim SE, Suh YL, Na DL.
      Serial positron emission tomography findings in a patient with hydrocephalic dementia and Alzheimer's disease.
      J Neuroimaging. 2004 Apr;14(2):170-5.
    3. Cai L, Chin FT, Pike VW, Toyama H, Liow JS, Zoghbi SS, Modell K, Briard E, Shetty HU, Sinclair K, Donohue S, Tipre D, Kung MP, Dagostin C, Widdowson DA, Green M, Gao W, Herman MM, Ichise M, Innis RB.
      Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.
      J Med Chem. 2004 Apr 22;47(9):2208-18.
    4. Patwardhan MB, McCrory DC, Matchar DB, Samsa GP, Rutschmann OT.
      Alzheimer disease: operating characteristics of PET--a meta-analysis. Radiology.
      2004 Apr;231(1):73-80. Epub 2004 Feb 27. Review.
    5. Rohren EM, Turkington TG, Coleman RE.
      Clinical applications of PET in oncology.
      Radiology. 2004 May;231(2):305-32. Epub 2004 Mar 24.
    6. Minoshima S.
      Imaging Alzheimer's disease: clinical applications.
      Neuroimaging Clin N Am. 2003 Nov;13(4):769-80. Review.
    7. Mosconi L, Pupi A, De Cristofaro MT, Fayyaz M, Sorbi S, Herholz K.
      Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease.
      J Nucl Med. 2004 Mar;45(3):382-92.
    8. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B.
      Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
      Ann Neurol. 2004 Mar;55(3):306-19.
    9. Mosconi L, Nacmias B, Sorbi S, De Cristofaro MT, Fayazz M, Tedde A, Bracco L, Herholz K, Pupi A.
      Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
      J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):370-6.
    10. Nordberg A.
      Toward an early diagnosis and treatment of Alzheimer's disease.
      Int Psychogeriatr. 2003 Sep;15(3):223-37.
    11. Verkkoniemi A, Ylikoski R, Rinne JO, Somer M, Hietaharju A, Erkinjuntti T, Viitanen M, Kalimo H, Haltia M.
      Neuropsychological functions in variant Alzheimer's disease with spastic paraparesis.
      J Neurol Sci. 2004 Mar 15;218(1-2):29-37.
    12. Boles Ponto LL, Schultz SK, Leonard Watkins G, Hichwa RD.
      Technical issues in the determination of cerebrovascular reserve in elderly subjects using 15O-water PET imaging.
      Neuroimage. 2004 Jan;21(1):201-10.
    13. Herholz K, Weisenbach S, Zundorf G, Lenz O, Schroder H, Bauer B, Kalbe E, Heiss WD.
      In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease.
      Neuroimage. 2004 Jan;21(1):136-43.
    14. Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust WJ, Clark CM, Barbas NR, Arnold SE, Turner RS, Heidebrink JL, Minoshima S.
      A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging.
      Stat Med. 2004 Jan 30;23(2):315-26.
    15. Rapoport SI.
      Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease.
      Neurotox Res. 2003;5(6):385-98. Review.
    16. Kostrzewa RM, Segura-Aguilar J.
      Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.
      Neurotox Res. 2003;5(6):375-83. Review.
    17. Jarvenpaa T, Laakso MP, Rossi R, Koskenvuo M, Kaprio J, Raiha I, Kurki T, Laine M, Frisoni GB, Rinne JO.
      Hippocampal MRI volumetry in cognitively discordant monozygotic twin pairs.
      J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):116-20.
    18. Haier RJ, Alkire MT, White NS, Uncapher MR, Head E, Lott IT, Cotman CW.
      Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia.
      Neurology. 2003 Dec 23;61(12):1673-9.
    19. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J.
      Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
      Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):284-9. Epub 2003 Dec 19.
    20. Suemoto T, Okamura N, Shiomitsu T, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Kudo Y, Sawada T.
      In vivo labeling of amyloid with BF-108.
      Neurosci Res. 2004 Jan;48(1):65-74.

    Diagnosi con la SPECT


    1. O'Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D, Aarsland D, McKeith IG.
      Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with lewy bodies.
      Arch Neurol. 2004 Jun;61(6):919-25.
    2. Kaneko K, Kuwabara Y, Sasaki M, Ogomori K, Ichimiya A, Koga H, Nakagawa M, Hayashi K, Honda H.
      Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT.
      Clin Nucl Med. 2004 Jun;29(6):362-6.
    3. Okamura N.
      [In vivo imaging of amyloid plaques in the brain]
      Nippon Ronen Igakkai Zasshi. 2004 Mar;41(2):175-8. Japanese.
    4. Bonte FJ, Harris TS, Roney CA, Hynan LS.
      Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign.
      J Nucl Med. 2004 May;45(5):771-4.
    5. Okamura N, Suemoto T, Shimadzu H, Suzuki M, Shiomitsu T, Akatsu H, Yamamoto T, Staufenbiel M, Yanai K, Arai H, Sasaki H, Kudo Y, Sawada T.
      Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
      J Neurosci. 2004 Mar 10;24(10):2535-41.
    6. van Rhijn SJ, Glosser G, de Vries JJ, Clark CM, Newberg AB, Alavi A.
      Visual processing impairments and decrements in regional brain activity in Alzheimer's disease.
      J Clin Exp Neuropsychol. 2004 Feb;26(1):11-23.
    7. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG.
      The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
      Ann Neurol. 2004 Feb;55(2):164-73.
    8. Boles Ponto LL, Schultz SK, Leonard Watkins G, Hichwa RD.
      Technical issues in the determination of cerebrovascular reserve in elderly subjects using 15O-water PET imaging.
      Neuroimage. 2004 Jan;21(1):201-10.
    9. Vogel A, Stokholm J, Gade A, Andersen BB, Hejl AM, Waldemar G.
      Awareness of deficits in mild cognitive impairment and Alzheimer's disease: do MCI patients have impaired insight?
      Dement Geriatr Cogn Disord. 2004;17(3):181-7. Epub 2004 Jan 20.
    10. Rodriguez G, Vitali P, Canfora M, Calvini P, Girtler N, De Leo C, Piccardo A, Nobili F.
      Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease.
      Clin Neurophysiol. 2004 Jan;115(1):39-49.
    11. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O'Brien J, Playfer J, Reid W;
      International Psychogeriatric Association Expert Meeting on DLB. Dementia with Lewy bodies.
      Lancet Neurol. 2004 Jan;3(1):19-28. Review.
    12. Marshall V, Grosset D.
      Role of dopamine transporter imaging in routine clinical practice.
      Mov Disord. 2003 Dec;18(12):1415-23. Review.
    13. Kemp PM, Holmes C, Hoffmann S, Wilkinson S, Zivanovic M, Thom J, Bolt L, Fleming J, Wilkinson DG.
      A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease.
      J Neurol Neurosurg Psychiatry. 2003 Nov;74(11):1567-70.
    14. Wagner M, Teichner G, Bachman DL.
      Diagnostic challenges of using CSF assay of tau and beta-amyloid(42) in atypical degenerative dementias of the Alzheimer type.
      Arch Clin Neuropsychol. 2003 Dec;18(8):893-903.
    15. Lojkowska W, Ryglewicz D, Jedrzejczak T, Minc S, Jakubowska T, Jarosz H, Bochynska A.
      The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia.
      J Neurol Sci. 2003 Dec 15;216(1):119-26.
    16. Ceravolo R, Volterrani D, Gambaccini G, Rossi C, Logi C, Manca G, Berti C, Mariani G, Murri L, Bonuccelli U.
      Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease.
      Neurol Sci. 2003 Oct;24(3):162-3.
    17. [No authors listed]
      [Alzheimer's dementia. Advances in diagnosis and therapy]
      MMW Fortschr Med. 2003 May 26;145 Suppl 2:20-1. German. No abstract available.
    18. Marksteiner J, Walch T, Bodner T, Gurka P, Donnemiller E.
      Fluoxetine in Alzheimer's disease with severe obsessive compulsive symptoms and a low density of serotonin transporter sites.
      Pharmacopsychiatry. 2003 Sep;36(5):207-9.
    19. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT.
      Regional cerebral blood flow in Parkinson's disease with and without dementia.
      Neuroimage. 2003 Oct;20(2):1309-19.
    20. Costa DC, Walker Z, Walker RW, Fontes FR.
      Dementia with Lewy bodies versus Alzheimer's disease: role of dopamine transporter imaging.
      Mov Disord. 2003 Oct;18 Suppl 7:S34-8.

    Terapia


    1. Nauck F, Klaschik E.
      [Cannabinoids in the treatment of the cachexia-anorexia syndrome in palliative care patients]
      Schmerz. 2004 Jun;18(3):197-202. German.
    2. Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF.
      Postmenopausal estrogen use affects risk for Parkinson disease.
      Arch Neurol. 2004 Jun;61(6):886-8.
    3. Heppner FL, Gandy S, McLaurin J.
      Current concepts and future prospects for Alzheimer disease vaccines.
      Alzheimer Dis Assoc Disord. 2004 Jan-Mar;18(1):38-43.
    4. Wolozin B, Brown J 3rd, Theisler C 3rd, Silberman S 3rd.
      The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease.
      CNS Drug Rev. 2004 Summer;10(2):127-46.
    5. Lorigados-Pedre L, Bergado-Rosado JA.
      [Nerve growth factor in neurodegeneration and neurorestorative therapy]
      Rev Neurol. 2004 May 16-31;38(10):957-71. Spanish.
    6. Dobson CM.
      Protein chemistry. In the footsteps of alchemists.
      Science. 2004 May 28;304(5675):1259-62. No abstract available.
    7. Rive B, Vercelletto M, Damier FD, Cochran J, Francois C.
      Memantine enhances autonomy in moderate to severe Alzheimer's disease.
      Int J Geriatr Psychiatry. 2004 May;19(5):458-64.
    8. Condefer KA, Haworth J, Wilcock GK.
      Clinical utility of computed tomography in the assessment of dementia: a memory clinic study.
      Int J Geriatr Psychiatry. 2004 May;19(5):414-21.
    9. Yatomi N.
      [Prevention of senile dementia]
      Seishin Shinkeigaku Zasshi. 2004;106(1):68-72. Review. Japanese. No abstract available.
    10. Farran CJ, Loukissa DA, Lindeman DA, McCann JJ, Bienias JL.
      Caring for self while caring for others: the two-track life of coping with Alzheimer's disease.
      J Gerontol Nurs. 2004 May;30(5):38-46.
    11. Kudo T.
      [Drug therapy for aged patients with Alzheimer disease]
      Seishin Shinkeigaku Zasshi. 2004;106(1):62-7. Review. Japanese. No abstract available.
    12. Tanimukai S.
      [Role of psychiatrists in early diagnosis of senile dementia]
      Seishin Shinkeigaku Zasshi. 2004;106(1):56-61. Review. Japanese. No abstract available.
    13. Takeda M.
      [Role of psychiatrists in long-term care for the aged]
      Seishin Shinkeigaku Zasshi. 2004;106(1):53-5. Review. Japanese. No abstract available.
    14. Gill SS, Mamdani M, Rochon PA.
      Management of overactive bladder.
      N Engl J Med. 2004 May 20;350(21):2213. No abstract available.
    15. Malaquin-Pavan E.
      [Developing clinical judgement through research]
      Soins. 2004 Apr;(684 Pt 1):46-8. French. No abstract available.
    16. Li F, Calingasan NY, Yu F, Mauck WM, Toidze M, Almeida CG, Takahashi RH, Carlson GA, Flint Beal M, Lin MT, Gouras GK.
      Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice.
      J Neurochem. 2004 Jun;89(5):1308-12.
    17. Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M, Flamez P, Dequenne A, Godaux E, van Leuven F, Fahrenholz F.
      A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.
      J Clin Invest. 2004 May;113(10):1456-64.
    18. Lichtenthaler SF, Haass C.
      Amyloid at the cutting edge: activation of alpha-secretase prevents amyloidogenesis in an Alzheimer disease mouse model.
      J Clin Invest. 2004 May;113(10):1384-7. Review.
    19. Qiu C, Kivipelto M, Aguero-Torres H, Winblad B, Fratiglioni L.
      Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.
      J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):828-33.
    20. Capizzano AA, Acion L, Bekinschtein T, Furman M, Gomila H, Martinez A, Mizrahi R, Starkstein SE.
      White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease.
      J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):822-7.

    Plone and its visual design is Copyright © 2000-2012 by Alexander Limi, Alan Runyan, Vidar Andersen.